Clindam
Capsules
Composition:
Each capsule contains: Clindamycin Hydrochloride equivalent
to 150 mg or 300 mg Clindamycin.
Properties:
Clindarnycin in-vitro activity covers the following
organisms: Gram-Positive: Aerobic organisms: Staphylococcus aureus,
Staphylococcus epidermis (both penicillinase and non-penicillinase producing
strains), Streptococci (except S.faecalis), pneumococci. Anaerobic organisms:
Non spore forming Bacilli such as Propionibacterium species. Gram-Negative:
Anaerobic Bacilli such as Bacteroides species and Fusobacterium species.
Indications:
Infections with
microorganisms susceptible to Clindamycin such as:
- Respiratory tract
infections.
- Skin and soft
tissue infections.
- Dental infections.
- Genital and post-surgical infections
. Contraindications:
Clindamycin demonstrates cross resistance with Lincomycin.
Some Staphylococcus strains originally resistant to Erythromycin rapidly
develop resistance to Clindamycin. Clindam is constrained in patients with
history of hypersensitivity to Clindamycin or Lincomycin.
Usage in
pregnancy:
Safety for use during
pregnancy has not been established.
Side Effects:
Gastrointestinal
disturbances: abdominal pain, nausea, vomiting and diarrhoea may occur.
Dosage:
Mild to moderately
severe infections: 150 to 300 mg every 6 hours. Severe infections: 300 to 450
mg every 6 hours.
Presentation:
Clindam 150 mg
capsules: A box containing 2 blisters, each of 8 capsules. Clindam 300 mg
capsules: A box containing 1 blister of 8 capsules. A box containing 2
blisters, each of 8 capsules.
ليست هناك تعليقات:
إرسال تعليق